Brower Piven Announces An Investigation Of The Acquisition Of American Medical Systems Holdings, Inc. By Endo Pharmaceuticals Holdings Inc.
The law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of American Medical Systems Holdings, Inc. (“AMS”) (NasdaqGS: AMMD) and other violations of state law by the Board of Directors of AMS relating to the proposed acquisition of the company by Endo Pharmaceuticals Holdings Inc. (“Endo”) (Nasdaq: ENDP). The firm’s investigation seeks to determine whether AMS and its Board breached their fiduciary duties by, among other things, failing to maximize shareholder value.
On April 11, 2011, AMS and Endo jointly announced that they have entered into a definitive merger agreement for AMS to be acquired by Endo. Under the terms of the merger agreement, which has been unanimously approved by the Boards of Directors of both companies, Endo will acquire 100 percent of the shares of AMS for $30 per share or a total cash consideration of $2.9 billion, which includes the assumption and repayment of $312 million of AMS debt. AMS has recently performed well, reporting revenue of $147 million for the fourth quarter of 2010, a 0.7 percent increase over sales of $146 million in the comparable quarter of 2009. Also, AMS reported fourth quarter net income of $27.2 million, or $0.35 per share, a growth of 17.7 percent compared to $22.3 million or $0.30 per share in the comparable quarter of 2009.
If you currently own shares of AMS and would like to learn more about
the investigation being conducted by Brower Piven, you may e-mail or
call Brower Piven, who will, without obligation or cost to you, attempt
to answer your questions. You may contact Brower Piven by email at
by calling 410/415-6616, or at Brower Piven, A Professional Corporation,
1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower
Piven have combined experience litigating securities and other class
action cases of over 60 years.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV